Who should not take P-21?
Documented caution flags for P-21 include pregnancy / nursing and anyone risk-averse to pre-clinical compounds. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for P-21 is limited.
Documented caution flags for P-21
- Pregnancy / nursing
- Anyone risk-averse to pre-clinical compounds
Reported side effects to weigh
- Limited human data
- Generally well tolerated in animal models
References
- Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound — Baazaoui N, Iqbal K. Alzheimer's Research & Therapy, 2017
- Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound — Baazaoui N, Iqbal K. Biomolecules, 2022
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on P-21
Last updated 2026-06-15.